Neuroeye

Izertis, together with Fernández-Vega Ophthalmological Institute (IOFV) and in collaboration with the Ophthalmic Research Foundation (FIO), is researching a new method for early diagnosis of neurodegenerative diseases such as Alzheimer’s or schizophrenia through observation of the retina. This tissue would be utilized as an accessible part of the central nervous system, since it suffers from the same degenerative processes as cerebral nerve tissue.
The initiative is known as ‘Neuroeye.’ Its goal is to research a non-invasive procedure that enables us to identify neurodegenerative lesions in the retina and in the cornea in order to diagnose diseases such as Alzheimer’s.
In this collaborative project, co-financed by the European Union, Izertis is in charge of the project’s technological section, through analysis of images and detection of patterns using techniques based in Deep Learning. The initiative has been made possible thanks to the ‘training’ of the algorithms to detect, by using the image of the retina, which patients suffer from a neurodegenerative disease.